Clinical trials of hydroxychloroquine vs. COVID-19 discontinued in USA

In the USA, clinical trials of the drug hydroxychloroquine, used in the treatment of patients hospitalized with COVID-19, were stopped due to the unproven effectiveness. This was reported by the press service of the National Institutes of Health (NIH) of the country. Clinical trials to assess the safety and effectiveness of hydroxychloroquine in the treatment of adults hospitalized with coronavirus disease (COVID-19) were stopped by the National Institutes of Health, the statement said. It is specified that a study of the effects of the drug showed its extremely unlikely benefit in the treatment of patients with COVID-19. However, the detrimental effect of the drug on the body of the person taking it was not revealed. Recall that earlier the US Department of Health abandoned the treatment scheme for COVID-19 with the drug hydroxychloroquine, which was found to be ineffective.

Комментарии

Популярные сообщения из этого блога

The court determined a preventive measure to the son of the ex-prime minister of Georgia

WHO: the number of detected cases of SARS-CoV-2 infection in the world exceeded 9.6 million

Charter flights to be allocated for those wishing to return from Turkey to Azerbaijan